Speaker Spotlight

Dr. Neena Haider is revolutionizing medicine by making the impossible possible—turning genetic diseases from life sentences into treatable conditions. As founder of Shifa Precision and former Harvard Medical School faculty member, she has dedicated her career to transforming how we prevent, diagnose, and treat disease at the most fundamental level: our genes.

Dr. Haider’s journey began as a key contributor to the Human Genome Project, where she helped unlock the blueprint of human life. This foundational work led to her identification of more than a dozen genes linked to devastating diseases including blindness, kidney disorders, and autism. But discovering disease-causing genes was only the beginning—Dr. Haider was determined to develop cures.

At Harvard Medical School, she pioneered novel gene therapies with broad capabilities to treat multiple rare and common forms of blindness. Her groundbreaking work earned U.S. patents, FDA orphan disease designations, Regenerative Medicine Advanced Therapy status, and European Medicines Agency approval for clinical trials. These therapies represent hope for millions who were previously told their conditions were untreatable.

Throughout her career, Dr. Haider has served in leadership roles at Harvard Medical School, the National Institutes of Health, U.S. Congress, National Science Foundation, and NASA, bringing scientific rigor to policy and practice. Her research has been published in leading journals, cited over 3,000 times, and incorporated into textbooks worldwide, establishing her as a global authority in genetics and gene therapy.

Recognizing that the future of medicine lies in prevention rather than reaction, Dr. Haider founded Shifa Precision, an AI-powered precision medicine platform that provides predictive health analysis to clinicians. This innovative approach empowers doctors to proactively identify and mitigate diseases before they manifest, fundamentally shifting healthcare from reactive treatment to predictive prevention.

Dr. Haider’s vision extends beyond treating individual patients to transforming entire healthcare systems, reducing costs while dramatically improving outcomes. Her work proves that when we understand our genetic code, we can rewrite our medical destiny.